
Viewpoint: A shot in the arm for generics producers
Domino inksThere is nowhere to hide from the Falsified Medicines Directive. It impacts generics producers in the same way as any other drug manufacturer or re-packager selling into Europe. With just under 48 months to go before the deadline, which is likely to be mid-2018, the clock is ticking for all producers to get their house in order.
The subject was hot on the agenda at the European Generics Association (EGA) meeting in Madrid earlier this month. As generics manufacturers often supply products with much lower margins than patented drug producers, their budgets are restricted when it comes to new investment – which is why many of them have been holding out until the last minute to find the ‘best-fit’ solution for their businesses.
Related Posts
Delhi: Fake pesticide manufacturing plant busted, one arrested
The Delhi Police busted a spurious pesticide manufacturing plant on Roshanara...
Over 10 retailers in Fairfield and Cabramatta are selling illicit tobacco By Bianca Perez
CABRAMATTA and Fairfield have been identified as Australia's top two suburbs to...
ASPA & MFI Join Hands to Host First International Authentication Conference in India
Spurred by rising cases of infringements, adulteration, foray of counterfeit...
560 people arrested in Nagaland for smuggling liquor & banned
Nagaland police has arrested 560 people for smuggling liquor and banned drugs...